Ticagrelor 60 vs. 90 mg in Elderly ACS Patients undergoing PCI: a Randomized, Crossover Trial
AbstractAims. Although dual antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 receptor inhibitor is currently recommended in patients with acute
Related Articles
Register for TCT 2024 | Washington, D.C.
October 27–30, 2024, Walter E. Washington Convention Center. Ignite innovation, education, and connection at the global forum for interventional cardiology.
Anticoagulation in Device-Detected AF With or Without Vascular Disease – American College of Cardiology
Geoffrey D. Barnes, MD, MSc, FACC
Beyond the Data: ASSURE DES
Mamas Mamas and Jung-Min Ahn discuss managing antiplatelet therapy before noncardiac surgery after a prior stenting.
Understanding the Optimal Evaluation and Management of Patients With HF: An Interview with Drs. Januzzi and Stevenson – American College of Cardiology
It is imperative that clinicians understand the differences in each patient and how effective therapies must be individualized and often combined to treat patients with…
A systematic review of nirmatrelvir/ritonavir and molnupiravir for the treatment of COVID-19
AbstractBackground. To address the need for treatments for patients with COVID-19, three therapies have been given either full approval or Emergency Use Au
Vascular Renaissance Award for Limb Saving Tech | PAD Impact Awards
Watch to see who is the recipient of the ” Vascular Renaissance” Award.The “Vascular Renaissance Award” honors groundbreaking advancements in limb salvage te…
Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial
Percutaneous radiofrequency ablation may provide therapeutic effects similar to those of laparoscopic liver resection for patients with hepatocellular carc
Legislative Republicans rush to fix terrible threat of voters making decisions
The GOP-controlled Utah Legislature rushes to protect themselves from voter-approved ballot initiatives
Healthcare misconceptions from 98 health system execs
Becker’s asked C-suite executives from hospitals and health systems across the U. S. to share the biggest misconception about healthcare this year.
